Skip to main content
Fig. 4 | Alzheimer's Research & Therapy

Fig. 4

From: Tau-PET and in vivo Braak-staging as prognostic markers of future cognitive decline in cognitively normal to demented individuals

Fig. 4

Rates of clinical conversion during follow-up stratified by amyloid-PET positivity, tau-PET positivity and Braak-stage group. Barplots show relative risk of clinical conversion from cognitive normal (CN) to mild cognitive impairment (MCI) or dementia, and from MCI to dementia. Note that subjects with a baseline diagnosis of dementia were excluded from this analysis, since no further diagnostic change can be observed in these participants

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193